|
1
|
Antoni S, Ferlay J, Soerjomataram I, Znaor
A, Jemal A and Bray F: Bladder cancer incidence and mortality: A
global overview and recent trends. EurUrol. 71:96–108. 2017.
|
|
2
|
NCI, . SEER stat fact sheets: Bladder
cancer. 18–20142014.
|
|
3
|
World Health Organization, . World Cancer
Report 2014 Chapter 1. 1 ISBN 9283204298. 2014.
|
|
4
|
Cancer Research UK: Bladder cancer key
stats. 29–2014
|
|
5
|
Shen Z, Shen T, Wientjes MG, O'Donnell MA
and Au JL: Intravesical treatments of bladder cancer: Review. Pharm
Res. 25:1500–1510. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dinney CP, McConkey DJ, Millikan RE, Wu X,
Bar-Eli M, Adam L, Kamat AM, Siefker-Radtke AO, Tuziak T, Sabichi
AL, et al: Focus on bladder cancer. Cancer Cell. 6:111–116. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Allona Moncada A, García Vaquero S,
Zuloaga Gómez A, Martínez Torres JL, López-Pardo R, Molina J,
Camacho JE, Rodríguez Rubio F and Varo C: Preliminary results of a
multicenter study with mitomycin C in superficial bladder tumors
(Ta, T1). Actas Urol Esp. 12:424–429. 1988.(In Spanish). PubMed/NCBI
|
|
8
|
van der Meijden AP and DeBruyne FM:
Treatment schedule of intravesical chemotherapy with mitomycin C in
superficial bladder cancer: Short-term courses or maintenance
therapy. Urology. 31(3 Suppl): S26–S29. 1988.
|
|
9
|
Colombo R, Lev A, Da Pozzo LF, Freschi M,
Gallus G and Rigatti P: A new approach using local combined
microwave hyperthermia and chemotherapy in superficial transitional
bladder carcinoma treatment. J Urol. 153:959–963. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kondás J, Kiss L, Határ A, Kiss A, Lukács
T, Szeldeli P, Törzsök F and Bodrogi I: The effect of intravesical
mitomycin C on the recurrence of superficial (Ta-T1) bladder
cancer. A hungarian multicenter study. Int Urol Nephrol.
31:451–456. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Di Stasi SM, Giannantoni A, Stephen RL,
Capelli G, Navarra P, Massoud R and Vespasiani G: Intravesical
electromotive mitomycin C versus passive transport mitomycin C for
high risk superficial bladder cancer: A prospective randomized
study. J Urol. 170:777–782. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Moertel CG, Reitemeier RJ and Hahn RG:
Mitomycin C therapy in advanced gastrointestinal cancer. JAMA.
204:1045–1048. 1968. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lenaz L: Mitomycin C in advanced breast
cancer. Cancer Treat Rev. 12:235–249. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu BH, Gupta V and Singh SV: Mechanism of
differential sensitivity of human bladder cancer cells to mitomycin
C and its analogue. Br J Cancer. 69:242–246. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zargar H, Aning J, Ischia J, So A and
Black P: Optimizing intravesical mitomycin C therapy in
non-muscle-invasive bladder cancer. Nat Rev Urol. 11:220–230. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cooper GM and Hausman RE: The cell: A
molecular approach. Washington, DC: ASM PRESS; pp. 5442009
|
|
17
|
Oberg F, Ekvall M, Nyblom M, Backmark A,
Neutze R and Hedfalk K: Insight into factors directing high
production of eukaryotic membrane proteins; production of 13 human
AQPs in Pichia pastoris. Mol Membr Biol. 26:215–227. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shi YH, Chen R, Talafu T, Nijiati R and
Lalai S: Significance and expression of aquaporin 1, 3, 8 in
cervical carcinoma in xinjianguygur women of China. Asian Pac J
Cancer Prev. 13:1971–1975. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Verkman AS, Hara-Chikuma M and
Papadopoulos MC: Aquaporins-new players in cancer biology. J Mol
Med (Berl). 86:523–529. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Deb P, Pal S, Dutta V, Boruah D, Chandran
VM and Bhatoe HS: Correlation of expression pattern of aquaporin-1
in primary central nervous system tumors with tumor type, grade,
proliferation, microvessel density, contrast-enhancement and
perilesional edema. J Cancer Res Ther. 8:571–577. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu J, Zhang WY and Ding DG: Expression of
aquaporin 1 in bladder uroepithelial cell carcinoma and its
relevance to recurrence. Asian Pac J Cancer Prev. 16:3973–3976.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shrestha YB, Wickwire K and Giraudo S:
Effect of reducing hypothalamic ghrelin receptor gene expression on
energy balance. Peptides. 30:1336–1341. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kang M, Jeong C, Ku JH, Kwak C and Kim HH:
Inhibition of autophagy potentiates atorvastatin-induced apoptotic
cell death in human bladder cancer cells in vitro. Int J Mol Sci.
15:8106–8121. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gong YQ, Peng D, Ning XH, Yang XY, Li XS,
Zhou LQ and Guo YL: UBE2T silencing suppresses proliferation and
induces cell cycle arrest and apoptosis in bladder cancer cells.
Oncol Lett. 12:4485–4492. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Danshiitsoodol N, de Pinho CA, Matoba Y,
Kumagai T and Sugiyama M: The mitomycin C (MMC)-binding protein
from MMC-producing microorganisms protects from the lethal effect
of bleomycin: Crystallographic analysis to elucidate the binding
mode of the antibiotic to the protein. J Mol Biol. 360:398–408.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liang Y and Zhu D: Subjective well-being
of Chinese landless peasants in relatively developed regions:
Measurement using PANAS and SWLS. Social Indicat Res.
123:pp817–835. 2015. View Article : Google Scholar
|
|
28
|
Liang Y: Trust in Chinese government and
quality of life (QOL) of sichuan earthquake survivors: Does trust
in government help to promote QOL? Social Indicat Res. 127:541–564.
2016. View Article : Google Scholar
|
|
29
|
Shi YH, Rehemu N, Ma H, Tuokan T, Chen R
and Suzuke L: Increased migration and local invasion potential of
SiHa cervical cancer cells expressing Aquaporin 8. Asian Pac J
Cancer Prev. 14:1825–1828. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shi YH, Tuokan T, Lin C and Chang H:
Aquaporin 8 involvement in human cervical cancer SiHa migration via
the EGFR-Erk1/2 pathway. Asian Pac J Cancer Prev. 15:6391–6395.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Warth A, Muley T, Meister M, Herpel E,
Pathil A, Hoffmann H, Schnabel PA, Bender C, Buness A, Schirmacher
P and Kuner R: Loss of aquaporin-4 expression and putative function
in non-small cell lung cancer. BMC Cancer. 11:1612011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zou LB, Shi S, Zhang RJ, Wang TT, Tan YJ,
Zhang D, Fei XY, Ding GL, Gao Q, Chen C, et al: Aquaporin-1 plays a
crucial role in estrogen-induced tubulogenesis of vascular
endothelial cells. J Clin Endocrinol Metab. 98:E672–E682. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shi YH, Chen R, Talafu T, Nijiati R and
Lalai S: Significance and expression of aquaporin 1, 3, 8 in
cervical carcinoma in Xinjiang Uygur women of China. Asian Pac J
Cancer Prev. 13:1971–1975. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
El Hindy N, Rump K, Lambertz N, Zhu Y,
Frey UH, Bankfalvi A, Siffert W, Sure U, Peters J, Adamzik M and
Sandalcioglu IE: The functional aquaporin 1-783G/C-polymorphism is
associated with survival in patients with glioblastoma multiforme.
J Surg Oncol. 108:492–498. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Morrissey JJ, Mobley J, Song J, Vetter J,
Luo J, Bhayani S, Figenshau RS and Kharasch ED: Urinary
concentrations of aquaporin-1 and perilipin-2 in patients with
renal cell carcinoma correlate with tumor size and stage but not
grade. Urol. 83:256.e9–e14. 2014. View Article : Google Scholar
|
|
36
|
Morrissey JJ, Mobley J, Figenshau RS,
Vetter J, Bhayani S and Kharasch ED: Urine aquaporin 1 and
perilipin 2 differentiate renal carcinomas from other imaged renal
masses and bladder and prostate cancer. Mayo Clin Proc. 90:pp.
35–42. 2015; View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tan M, Shao C, Bishop JA, Feng Z, Trock
BJ, Westra WH and Ha PK: Aquaporin-1 promoter hypermethylation is
associated with improved prognosis in salivary gland adenoid cystic
carcinoma. Otolaryngol Head Neck Surg. 150:801–807. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Stigliano C, Aryal S, de Tullio MD,
Nicchia GP, Pascazio G, Svelto M and Decuzzi P: siRNA-chitosan
complexes in poly(lactic-co-glycolic acid) nanoparticles for the
silencing of aquaporin-1 in cancer cells. Mol Pharm. 10:3186–3194.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xu B, Hua J, Zhang Y, Jiang X, Zhang H, Ma
T, Zheng W, Sun R, Shen W, Sha J, et al: Proliferating cell nuclear
antigen (PCNA) regulates primordial follicle assembly by promoting
apoptosis of oocytes in fetal and neonatal mouse ovaries. PLoS One.
6:e160462011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Paunesku T, Mittal S, Protić M, Oryhon J,
Korolev SV, Joachimiak A and Woloschak GE: Proliferating cell
nuclear antigen (PCNA): Ringmaster of the genome. Int J Radiat
Biol. 77:1007–1021. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang X, Barile G, Chang S, Hays A,
Pachydaki S, Schiff W and Sparrow J: Apoptosis and cell
proliferation in proliferative retinal disorders: PCNA, Ki-67,
caspase-3, and PARP expression. Curr Eye Res. 30:395–403. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lamkanfi M, Festjens N, Declercq W, Vanden
Berghe T and Vandenabeele P: Caspases in cell survival,
proliferation and differentiation. Cell Death Differ. 14:44–55.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Huang Q, Li F, Liu X, Li W, Shi W, Liu FF,
O'Sullivan B, He Z, Peng Y, Tan AC, et al: Caspase 3-mediated
stimulation of tumor cell repopulation during cancer radiotherapy.
Nat Med. 17:860–866. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
44
|
Tsujimoto Y, Finger LR, Yunis J, Nowell PC
and Croce CM: Cloning of the chromosome breakpoint of neoplastic B
cells with the t(14;18) chromosome translocation. Science.
226:1097–1099. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Cleary ML, Smith SD and Sklar J: Cloning
and structural analysis of cDNAs for bcl-2 and a hybrid
bcl-2/immunoglobulin transcript resulting from the t(14;18)
translocation. Cell. 47:19–28. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
EI-Emshaty HM, Saad EA, Toson EA, Abdel
Malak CA and Gadelhak NA: Apoptosis and cell proliferation:
Correlation with BCL-2 and P53 oncoprotein expression in human
hepatocellular carcinoma. Hepatogastroenterology. 61:1393–1401.
2014.PubMed/NCBI
|
|
47
|
Koshida Y, Saegusa M and Okayasu I:
Apoptosis, cell proliferation and expression of Bcl-2 and Bax in
gastric carcinomas: Immunohistochemical and clinicopathological
study. Br J Cancer. 75:367–373. 1997. View Article : Google Scholar : PubMed/NCBI
|
